Indeed, AML patients with high RAB27B, but not RAB27A, expression were sensitive to 4 different MEK inhibitors, as evidenced by lower AUC values (Figure 7D and Supplemental Figure 9A). Here, MAP2K7 is linked to acute myeloid leukemia.